The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
March 26th 2024
The FDA identified high concentration of lidocaine across marketed, over-the-counter topical products from 6 different companies.
The Latest on Acute Lymphocytic Leukemia
View More
A Focus on Acute Myeloid Leukemia
View More
Updates in Myelodysplastic Syndromes
View More
Earn CME Credits While Advancing Your Expertise in Internal Medicine
April 18-19, 2024
Register Now!
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?
View More
Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma
View More
Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer
View More
Medical Crossfire®: Exchange Between Onco-Nursing Experts on MPN Treatment and Symptom Management Along the Care Continuum
View More
Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
Community Practice Connections™: 16th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Go To PER in Chicago
May 31, 2024 - June 2, 2024
Register Now!
The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward
View More
Patient, Provider, and Caregiver Connection™: Individualizing Care for Patients with Schizophrenia—Understanding Patient Challenges and the Role of Innovative Treatment
View More
Expert Illustrations & Commentaries™: Exploring the Mechanistic Rationale for Targeting FGFR2 and Pan-FGFR in CCA
View More
Expert Illustrations and Commentaries™: Emerging Therapies and Treatment Strategies to Improve Care for Your Patients with Anemia in CKD
View More
Oncology Consultations®: Next Generation SERDs—Key Data and Practical Takeaways for the Community Physician
View More
Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients With CRPC
View More
Medical Crossfire®: Leveraging Multidisciplinary Teams in Early–Stage Breast Cancer When the Goal is Cure
View More
Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target
View More
The 14th Asia-Pacific Primary Liver Cancer Expert Meeting
July 18 - 20, 2024
Register Now!
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
Advances In™: Targeting PSMA to Advance Diagnosis And Management Of Patients With Prostate Cancer
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
New Rheumatoid Arthritis Network Aims to Personalize Treatment
October 26th 2009A new network from the University of Alabama at Birmingham (UAB) will create a national database that aims to see how rheumatoid arthritis (RA) patients respond to different RA drugs, and then use that information to further personalize RA treatment.
Key Advances in Rheumatology: A Decade of Progress
October 22nd 2009The journal Arthritis Research and Therapy has recently published its 10th anniversary issue, “The Scientific Basis of Rheumatology: A Decade of Progress,” which includes 38 articles that review some of “the most important advances in rheumatology research from the past decade.
Fibromyalgia and Soft Tissue Disorders II-Central Nervous System
A handful of abstracts were presented during this session, focusing on the link between fibromyalgia fatigue and kynurenine pathway activity, glutamate in the anterior insula, the effects of fatigue on response to pain, and neurocortical representation of locus of control in patients with fibromyalgia.
Community Resources and Participation
During this hour-and-one-half concurrent abstract session, moderated by Jennifer M. Hootman, PhD, Centers for Disease Control and Prevention, Atalanta, GA, a half-dozen abstracts were presented, focusing on health-related quality of life among adults with arthritis, the impact of arthritis and other chronic conditions on community participation, quality of non-pharmacologic care for patients with osteoarthritis, social network support, and restrictions in participating in life situations among patients with RA.
Childhood Arthritis and Rheumatic Disease Education (CARE)
October 21st 2009This morning's presentation on implementing a CARE (Childhood Arthritis and Rheumatic Disease Education) Program was comprised of a step-by-step case study. Barbara A. Paliughi, RN, BSN, and Linda L. Miranda, RN, BSN, relayed their experience of getting this type of program off the ground at their place of employment, the Children's Hospital of Central California.
Fibromyalgia and Soft Tissue Disorders: Late Morning Poster Tour Recap
Among the numerous posters on display under the "Fibromyalgia and Soft Tissue Disorders" heading on day 4 at the American College of Rheumatology/Association of Rheumatology Health Professionals 2009 Annual Scientific Sessions were posters focused on the development of a fibromyalgia (FM) responder index, anxiety and depression among patients with FM, tai chi as an effective treatment of FM, and sex differences in predictors of increased symptoms after exercise and sleep restriction in patients with such chronic pain disorders as fibromyalgia.
Fibromyalgia and Soft Tissue Disorders: Morning Poster Session Recap
Dozens of posters were presented under the "Fibromyalgia and Soft Tissue Disorders" umbrella during the morning of day 4 at the American College of Rheumatology/Association of Rheumatology Health Professionals 2009 Annual Scientific Sessions. Among the highlights are the following.
Rheumatoid Arthritis: Biologic Agents
Objectives for this presentation included identifying biologic agents in the use of RA; discussing the role of TNF inhibitors in rheumatoid arthritis; describing the role of B-cells in rheumatoid arthritis; and discussing what advances need to happen in order to better treat this condition.
Research Campaign Already Improving Lives of RA Patients
October 19th 2009The ACR's "Within Our Reach: Finding a Cure for Rheumatoid Arthritis" campaign has funded research that identified a highly-specific marker of RA, helps predict response to anti-TNF therapy, and improving doctor-patient communication.
Curbside Consult: Fibromyalgia
The 2009 American College of Rheumatology/Association of Rheumatology Health Professionals Scientific Meeting will feature several “Curbside Consult/Ask the Professors” sessions. Designed to feature information and discussion about “difficult management decisions that must be made in the absence of strong data,” these sessions give attendees the opportunity to “compare their personal management approaches” to the clinical problems outlined in the featured vignettes and scenarios with those of “the academic expert consultants and other clinicians in the audience.”
It's Not All in the Mind: Cognitive Function and Fibromyalgia
The Monday morning sessions at the 2009 American College of Rheumatology/Association of Rheumatology Health Professionals featured several presentations that focused on cognitive functioning in fibromyalgia and lupus.
What's the Best Way to Treat Fibromyalgia? A Holistic Approach
Fibromyalgia is a complex illness, especially when there are some healthcare professionals who do not consider it to be an illness. However, there is a high prevalence of fibromyalgia (3-4.7% of the general population) and patients who have it experience poor quality of life and place a high economic burden on themselves, their families, and society.
People with RA Not at Increased Risk of Serious Infection with Biologic Therapy
October 18th 2009The most important risk factors for serious infections were not biologic medications, as some might have expected, but instead were age, medical conditions such as emphysema, and RA-specific factors like disease duration.